FTC Urges Pa. Judge Not To Extend Deadline For Abbvie Docs
The Federal Trade Commission on Tuesday hit back at Abbvie Inc.'s Monday assertion that the agency is bringing up "new purported discovery disputes" in a pay-for-delay suit over the testosterone treatment...To view the full article, register now.
Already a subscriber? Click here to view full article